<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>作为您在 Google 上的首选新闻来源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>Assertio Holdings, Inc. (ASRT) 周三宣布，Zydus Worldwide DMCC（Zydus Lifesciences Ltd. 的子公司）同意以约 1.664 亿美元现金收购 Assertio，或每股 23.50 美元。</p>
<p>该交易预计将在 2026 年第二季度完成。</p>
<p>该报价相较于 4 月 8 日与 GUARD.ST 宣布的每股 18 美元的全现金交易溢价 30.6%。</p>
<p>该报价还相较于 5 月 4 日宣布的修订后每股 21.80 美元的 Garda 交易溢价 7.8%。</p>
<p>该交易进一步相较于 Assertio 在 3 月 20 日的未受影响收盘股价溢价 75.8%。</p>
<p>公司还表示，董事会确定 Zydus 的报价构成修订后的 Garda 合并协议下的 “优越提案”，并授权终止 Garda 协议以进入 Zydus 交易。</p>
<p>根据协议，Zydus 将开始以每股 23.50 美元现金收购所有未流通的 Assertio 普通股的要约。</p>
<p>交易完成后，Assertio 的普通股将不再在纳斯达克上市。</p>
<p>Zydus Lifesciences 在国家证券交易所的交易收盘上涨 0.92%，报 939.25 印度卢比。</p>
<p>在盘前交易中，Assertio 上涨 3.68%，报 23.38 美元，纳斯达克。</p>
<p>如有意见和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

ASRT

<p>Assertio Holdings, Inc. (ASRT) 宣布，Zydus Worldwide DMCC（Zydus Lifesciences Ltd. 的子公司）将以约 1.664 亿美元现金收购 Assertio，折合每股 23.50 美元。该交易预计将在 2026 年第二季度完成，较 Garda 之前的报价溢价 30.6%。Assertio 的董事会认为 Zydus 的报价是 “优越提案”，因此终止了与 Garda 的协议。收购完成后，Assertio 的股票将从纳斯达克退市</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>作为您在 Google 上的首选新闻来源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>Assertio Holdings, Inc. (ASRT), on Wednesday, announced that Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Ltd. (ZYDUSLIFE.BO,ZYDUSLIFE.NS), agreed to acquire Assertio for approximately $166.4 million in cash, or $23.50 per share.</p>
<div class="lb-trans"><p>Assertio Holdings, Inc. (ASRT) 周三宣布，Zydus Worldwide DMCC（Zydus Lifesciences Ltd. 的子公司）同意以约 1.664 亿美元现金收购 Assertio，或每股 23.50 美元。</p>
</div><p>The transaction is expected to close in the second quarter of 2026.</p>
<div class="lb-trans"><p>该交易预计将在 2026 年第二季度完成。</p>
</div><p>The offer represents a 30.6% premium to the $18 per share all-cash transaction with GUARD.ST announced on April 8.</p>
<div class="lb-trans"><p>该报价相较于 4 月 8 日与 GUARD.ST 宣布的每股 18 美元的全现金交易溢价 30.6%。</p>
</div><p>The offer also represents a 7.8% premium to the revised $21.80 per share Garda transaction announced on May 4.</p>
<div class="lb-trans"><p>该报价还相较于 5 月 4 日宣布的修订后每股 21.80 美元的 Garda 交易溢价 7.8%。</p>
</div><p>The transaction further represents a 75.8% premium to Assertio's unaffected closing stock price on March 20.</p>
<div class="lb-trans"><p>该交易进一步相较于 Assertio 在 3 月 20 日的未受影响收盘股价溢价 75.8%。</p>
</div><p>The company also said that the board determined that the Zydus offer constituted a &#34;Superior Proposal&#34; under the revised Garda merger agreement and authorized the termination of the Garda agreement to enter into the Zydus transaction.</p>
<div class="lb-trans"><p>公司还表示，董事会确定 Zydus 的报价构成修订后的 Garda 合并协议下的 “优越提案”，并授权终止 Garda 协议以进入 Zydus 交易。</p>
</div><p>Under the agreement, Zydus will commence a tender offer to acquire all outstanding shares of Assertio common stock for $23.50 per share in cash.</p>
<div class="lb-trans"><p>根据协议，Zydus 将开始以每股 23.50 美元现金收购所有未流通的 Assertio 普通股的要约。</p>
</div><p>Following completion of the transaction, Assertio's common stock will no longer be listed on Nasdaq.</p>
<div class="lb-trans"><p>交易完成后，Assertio 的普通股将不再在纳斯达克上市。</p>
</div><p>Zydus Lifesciences closed trading 0.92% higher at INR 939.25 on the National Stock Exchange.</p>
<div class="lb-trans"><p>Zydus Lifesciences 在国家证券交易所的交易收盘上涨 0.92%，报 939.25 印度卢比。</p>
</div><p>In the pre-market trading, Assertio is 3.68% higher at $23.38 on the Nasdaq.</p>
<div class="lb-trans"><p>在盘前交易中，Assertio 上涨 3.68%，报 23.38 美元，纳斯达克。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意见和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

Assertio 终止了与 Garda 的协议，并同意以 1.664 亿美元被 Zydus Worldwide DMCC 收购